A new drug has been added to the Pharmaceutical Benefits Scheme which can help stop breast cancer from spreading. The drug, also known as abemaciclib, will be made available to patients with a high-risk of cancer reoccurrence from next week.
A new drug has been added to the Pharmaceutical Benefits Scheme which can help stop breast cancer from spreading. The drug, also known as abemaciclib, will be made available to patients with a high-risk of cancer reoccurrence from next week.